5,7-Dihydroxitryptamine toxicity to serotonergic neurons in serum free raphe cultures

European Journal of Pharmacology

Volumn 588, Issue 2-3, 2008, Pages 232-238

  Capela, João Paulo ^a   Lautenschlager, Marion ^b   Dirnagl, Ulrich ^b   Bastos, Maria Lourdes ^a   Carvalho, Félix ^a   Meisel, Andreas ^b  

^a Faculdade de Farmácia da Universidade do Porto   (Portugal)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

5,7 Dihydroxitryptamine; Neurotoxicity; Rat foetal raphe serum free cultures; Serotonergic neurons; Serotonin transporter; Tryptophan hydroxylase

Indexed keywords

5,7 DIHYDROXYTRYPTAMINE; ANTISERUM; FLUOXETINE; LACTATE DEHYDROGENASE; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CULTURE MEDIUM; DENDRITE; ENZYME RELEASE; FETUS; IMMUNOCYTOCHEMISTRY; NERVE ENDING; NERVE FIBER DEGENERATION; NERVE FIBER TRANSECTION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAPHE NUCLEUS; RAT; SEROTONINERGIC NERVE CELL;

5,7-DIHYDROXYTRYPTAMINE; ANIMALS; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOXETINE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NERVE DEGENERATION; NERVE FIBERS; RAPHE NUCLEI; RATS;

EID: 44649125995     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.04.046     Document Type: Article

References (34)

1. Azmitia E. Modern views on an ancient chemical: serotonin effects on cell proliferation, maturation, and apoptosis. Brain Res. Bull. 56 (2001) 413-424
2. Baumgarten H.G., and Bjorklund A. Neurotoxic indoleamines and monoamine neurons. Annu. Rev. Pharmacol. Toxicol. 16 (1976) 101-111
3. Baumgarten H.G., and Lachenmayer L. Serotonin neurotoxins-past and present. Neurotox Res. 6 (2004) 589-614
4. Björklund A., Baumgarten H.G., and Rensch A. 5,7-Dihydroxytryptamine: improvement of its selectivity for serotonin neurons in the CNS by pretreatment with desipramine. J. Neurochem. 24 (1975) 833-835
5. Brewer G.J. Serum-free B27/neurobasal medium supports differentiated growth of neurons from the striatum, substantia nigra, septum, cerebral cortex, cerebellum, and dentate gyrus. J. Neurosci. Res. 42 (1995) 674-683
6. Callahan B.T., Cord B.J., and Ricaurte G.A. Long-term impairment of anterograde axonal transport along fiber projections originating in the rostral raphe nuclei after treatment with fenfluramine or methylenedioxymethamphetamine. Synapse 40 (2001) 113-121
7. Capela J.P., Ruscher K., Lautenschlager M., Freyer D., Dirnagl U., Gaio A.R., Bastos M.L., Meisel A., and Carvalho F. Ecstasy-induced cell death in cortical neuronal cultures is serotonin 2A-receptor-dependent and potentiated under hyperthermia. Neuroscience 139 (2006) 1069-1081
8. Choi S., Patil V., and Fernstrom J. 5,7-Dihydroxytryptamine: regional brain concentrations following intraventricular administration to rats. Neurochemical Res. 26 (2001) 1145-1149
9. Choi S., Jonak E., and Fernstrom J.D. Serotonin reuptake inhibitors do not prevent 5,7-dihydroxytryptamine-induced depletion of serotonin in rat brain. Brain Res. 1007 (2004) 19-28
10. Czesak M., Burns A.M., Lenicov F.R., and Albert P.R. Characterization of rat rostral raphe primary cultures: multiplex quantification of serotonergic markers. J. Neurosci. Meth. 164 (2007) 59-67
11. Frankfurt M., and Azmitia E. Regeneration of serotonergic fibers in the rat hypothalamus following unilateral 5,7-dihydroxytryptamine injection. Brain Res. 298 (1984) 273-282
12. Galter D., and Unsicker K. Regulation of the transmitter phenotype of rostral and caudal groups of cultured serotonergic raphe neurons. Neuroscience 88 (1999) 549-559
13. Galter D., Böttner M., and Unsicker K. Developmental regulation of the serotonergic transmitter phenotype in rostral and caudal raphe neurons by transforming growth factor-&bgr;s. J. Neurosci. Res. 56 (1999) 531-538
14. Green A.R., Mechan A.O., Elliot J.M., O'Shea E., and Colado M.I. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy"). Pharmacol. Rev. 55 (2003) 463-508
15. Gu X.F., and Azmitia E.C. Integrative transporter-mediated release from cytoplasmic and vesicular 5-hydroxytryptamine stores in cultured neurons. Eur. J. Pharmacol. 235 (1993) 51-57
16. Jacobs B.L., and Azmitia E.C. Structure and function of the brain serotonin system. Physiol. Rev. 72 (1992) 165-229
17. Klemm H.P., Baumgarten H.G., and Schlossberger H.G. Polarographic measurements of spontaneous and mitochondria-promoted oxidation of 5,6- and 5,7-dihydroxytryptamine. J. Neurochem. 35 (1980) 1400-1408
18. König N., Wilkie M.B., and Lauder J.M. Tyrosine hydroxylase and serotonin containing cells in embryonic rat rhombencephalon: a whole-mount immunocytochemical study. J. Neurosci. Res. 20 (1988) 212-223
19. Lautenschlager M., Holtje M., von Jagow B., Veh R.W., Harms C., Bergk A., Dirnagl U., Ahnert-Hilger G., and Hortnagl H. Serotonin uptake and release mechanisms in developing cultures of rat embryonic raphe neurons: age- and region-specific differences. Neuroscience 99 (2000) 519-527
20. Molliver M.E., Berger U.V., Mamounas L.A., Molliver D.C., O'Hearn E., and Wilson M.A. Neurotoxicity of MDMA and related compounds: anatomic studies. Ann. N. Y. Acad. Sci. 600 (1990) 649-664
21. O'Hearn E., Battaglia G., De Souza E.B., Kuhar M.J., and Molliver M.E. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. J. Neurosci. 8 (1988) 2788-2803
22. Ricaurte G.A., Forno L.S., Wilson M.A., DeLanney L.E., Irwin I., Molliver M.E., and Langston J.W. 3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates. J. Am. Med. Assoc. 260 (1988) 51-55
23. Rothman R.B., and Baumann M.H. Monoamine transporters and psychostimulant drugs. Eur. J. Pharmacol. 479 (2003) 23-40
24. Rumajogee P., Madeira A., Verge D., Hamon M., and Miquel M.-C. Up-regulation of the neuronal serotoninergic phenotype in vitro: BDNF and cAMP share Trk B-dependent mechanisms. J. Neurochem. 83 (2002) 1525-1528
25. Sanchez V., Camarero J., Esteban B., Peter M.J., Green A.R., and Colado M.I. The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ("ecstasy")-induced degeneration of 5-HT nerve endings in rat brain. Br. J. Pharmacol. 134 (2001) 46-57
26. Schmidt C.J. Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J. Pharmacol. Exp. Ther. 240 (1987) 1-7
27. Schmidt C.J., and Taylor V.L. Reversal of the acute effects of 3,4-methylenedioxymethamphetamine by 5-HT uptake inhibitors. Eur. J. Pharmacol. 181 (1990) 133-136
28. Tabatabaie T., and Dryhurst G. Chemical and enzyme-mediated oxidation of the serotonergic neurotoxin 5,7-dihydroxytryptamine: mechanistic insights. J. Med. Chem. 35 (1992) 2261-2274
29. Tabatabaie T., Wrona M.Z., and Dryhurst G. Autoxidation of the serotonergic neurotoxin 5,7-dihydroxytryptamine. J. Med. Chem. 33 (1990) 667-672
30. Tabatabaie T., Goyal R.N., Blank C.L., and Dryhurst G. Further insights into the molecular mechanisms of action of the serotonergic neurotoxin 5,7-dihydroxytryptamine. J. Med. Chem. 36 (1993) 229-236
31. Tork I. Anatomy of the serotonergic system. Ann. N.Y. Acad. Sci. 600 (1990) 9-34
32. Wang X., Baumann M.H., Xu H., and Rothman R.B. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein. Synapse 53 (2004) 240-248
33. Wichems C.H., Hollingsworth C.K., and Bennett B.A. Release of serotonin induced by 3,4-methylenedioxymethamphetamine (MDMA) and other substituted amphetamines in cultured fetal raphe neurons: further evidence for calcium-independent mechanisms of release. Brain Res. 695 (1995) 10-18
34. Xie T., Tong L., McLane M.W., Hatzidimitriou G., Yuan J., McCann U., and Ricaurte G.A. Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines. Neuropsychopharmacology 31 (2006) 2639-2651